You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD-34 selection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

Not yet recruiting
  • AML
  • +5 more
  • Infusion of CD34 selected hematopoietic stem cells
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 14, 2023

B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Cyclophosphamide injection
  • +2 more
  • Charleston, South Carolina
    Hollings Cancer Center at Medical University of South Carolina
Jan 18, 2023

Apheresis of Patients With Immunodeficiency

Recruiting
  • LAD-1
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Lymphoma Refractory, B-cell Lymphoma Recurrent Trial in Maywood (Fludarabine,

    Active, not recruiting
    • B-Cell Acute Lymphoblastic Leukemia, Adult
    • +2 more
    • Maywood, Illinois
      Loyola University
    Aug 11, 2022

    Malignant Non-Hodgkin Lymphomas Trial in Berne (CD34+ cell selection)

    Active, not recruiting
    • Malignant Non-Hodgkin Lymphomas
    • CD34+ cell selection
    • Berne, Switzerland
      Department for Medical Oncology; University Hospital/Inselspital
    Jul 29, 2021

    Hematologic Malignancies Trial in Chicago, New York (device, drug, radiation)

    Recruiting
    • Hematologic Malignancies
    • CliniMACS® CD34 Reagent System
    • +7 more
    • Chicago, Illinois
    • +1 more
    Sep 20, 2022

    Leukemia, Myelocytic, Acute Trial in United States (CD34+ selection with CliniMACS device)

    Completed
    Has Results
    • Leukemia, Myelocytic, Acute
    • CD34+ selection with CliniMACS device
    • Duarte, California
    • +7 more
    Oct 21, 2021

    Malignant Diseases (ie, Leukemia, MDS, Lymphoma), Non-malignant Diseases (ie, Bone Marrow Failure Syndromes) Trial in Milwaukee

    Completed
    • Malignant Diseases (ie, Leukemia, MDS, Lymphoma)
    • Non-malignant Diseases (ie, Bone Marrow Failure Syndromes)
    • CliniMACS (CD+3, CD+19 depletion)
    • +2 more
    • Milwaukee, Wisconsin
      Children's Hospital of Wisconsin
    Oct 21, 2021

    MDS (Myelodysplastic Syndrome), Myeloproliferative Disorder, Lymphoma, Non-Hodgkin Trial run by the NHLBI (Graft Manipulation

    Completed
    Has Results
    • MDS (Myelodysplastic Syndrome)
    • +4 more
    • Graft Manipulation (CD34+ Selection)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 20, 2020

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (CD34+ enriched, T Cell

    No longer available
    • Acute Lymphoblastic Leukemia
    • +11 more
    • CD34+ enriched, T Cell Depleted donor stem cell product
    • San Francisco, California
      University of California, San Francisco
    May 25, 2021

    Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected

    No longer available
    • Chronic Myeloid Leukemia
    • +2 more
    • G-CSF mobilized CD34+ selected cells for transplantation
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    Feb 28, 2022

    Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS

    Recruiting
    • Chronic Myeloid Leukemia (CML)
    • +5 more
    • CliniMACS CD34+ Reagent System
    • +8 more
    • New York, New York
      Columbia University Medical Center
    Jun 17, 2020

    Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia Trial in New York (CD34 Stem Cell Selection

    Active, not recruiting
    • Bone Marrow Failure Syndrome
    • +15 more
    • CD34 Stem Cell Selection Therapy
    • New York, New York
      Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
    Jun 17, 2020

    Hematologic Disorders Trial in Aurora (Miltenyi CliniMACS® CD34 Reagent System)

    Recruiting
    • Hematologic Disorders
    • Miltenyi CliniMACS® CD34 Reagent System
    • Aurora, Colorado
      University of Colorado
    Feb 22, 2022

    Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)

    Withdrawn
    • Hematologic Diseases
    • +5 more
    • CliniMACS
    • +7 more
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Sep 26, 2022

    Leukemia, Lymphoma, GVHD Trial in Australia, United States (cyclosporine, cyclosporine and methotrexate)

    Terminated
    • Leukemia
    • +2 more
    • Los Angeles, California
    • +12 more
    May 3, 2021

    Scleroderma, Cardiac Involvement, Autologous Stem Cell Transplantation Trial in Tuebingen (Autologous stemcell transplantation

    Active, not recruiting
    • Scleroderma
    • +2 more
    • Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells
    • Tuebingen, Germany
      University Hospital Tuebingen; Department of oncology, hematolog
    May 16, 2022

    MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Miami, Florida
      Miami Cancer Institute
    Jan 10, 2023

    Sickle Cell Disease Trial in Paris (DREPAGLOBE drug product)

    Active, not recruiting
    • Sickle Cell Disease
    • DREPAGLOBE drug product
    • Paris, France
      Department of Biotherapy, Necker-Enfants Malades Hospital
    Sep 26, 2022

    Retinitis Pigmentosa Trial in Sacramento (Intravitreal autologous CD34+ cells)

    Recruiting
    • Retinitis Pigmentosa
    • Intravitreal autologous CD34+ cells
    • Sacramento, California
      University of California Davis
    Sep 1, 2022

    Benign Tumor, Bone Marrow Transplantation Recipient, Hematopoietic Cell Transplantation Recipient Trial in Portland (Bone Marrow

    Available
    • Benign Neoplasm
    • +3 more
    • Bone Marrow Transplantation
    • +2 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Dec 9, 2021

    Hiv Trial in Philadelphia (Autologous CD4 T-Cells)

    Completed
    Has Results
    • Hiv
    • Autologous CD4 T-Cells
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Nov 13, 2022

    Graft Vs Host Disease, Graft-versus-host-disease Trial in San Francisco (CliniMacs®)

    Recruiting
    • Graft Vs Host Disease
    • Graft-versus-host-disease
    • CliniMacs®
    • San Francisco, California
      University of California, San Francisco
    Aug 2, 2022

    Mucopolysaccharidosis II Trial (Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII)

    Not yet recruiting
    • Mucopolysaccharidosis II
    • Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII
    • (no location specified)
    Dec 16, 2022

    Mitochondrial Diseases, Pearson Syndrome Trial in Ramat Gan (MNV-201)

    Recruiting
    • Mitochondrial Diseases
    • Pearson Syndrome
    • MNV-201
    • Ramat Gan, Israel
      Sheba Medical Center
    Aug 24, 2023